Research libraryMOLEKUL / SOURCE RECORD

GLADIOLUS observational study of Rumalon in osteoarthritis

L. I. Alekseeva, A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko · 2020 · Modern Rheumatology Journal 14(2), 76–83

Indexed 2026-11-12.

Uncontrolled human reportFull text availableSource linked

Reported findings and study design

Reported findings

Russian multicenter retrospective analysis of routine care over 12 weeks. The Russian protocols used 25 intramuscular injections, starting with 0.3 and 0.5 mL, then 1 mL per injection. Maintenance injections were given three times per week. Diacerein was 100 mg/day in the combination subgroup. Clinicians could use additional care.

Dose, route and schedule

Russian multicenter retrospective analysis of routine care over 12 weeks. The Russian protocols used 25 intramuscular injections, starting with 0.3 and 0.5 mL, then 1 mL per injection. Maintenance injections were given three times per week. Diacerein was 100 mg/day in the combination subgroup. Clinicians could use additional care.

Protocol source ↗ · Original Russian article

Results · Original Russian article
MeasureResultComparison, timing and statistics
Pain with movement at 12 weeksMedian 6 to 2 on a 0–10 scale. Pain at rest fell from 4 to 1, and functional impairment fell from 5 to 1.
NSAID use68.1% reportedly stopped taking NSAIDs.
Reported adverse eventsSkin allergic reactions in 0.3% and moderate injection-site pain in 0.37%. Gastrointestinal and cardiovascular events were reported in 8% and 6%, respectively.

All patients received Rumalon. Treatment selection and concurrent care can explain some of the change from baseline.

Source for these results ↗ · Reviewed 2026-11-12

For research and education. Consult a qualified clinician for medical advice.

Study limitations and source details

Study limitations

  • All patients received Rumalon. Treatment selection and concurrent care can explain some of the change from baseline.

Source access

Original Russian article

Source reviewed 2026-11-12.

Open source ↗

DOI: 10.14412/1996-7012-2020-2-76-83

Citation and original source

Original source: L. I. Alekseeva, A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko. GLADIOLUS observational study of Rumalon in osteoarthritis Modern Rheumatology Journal 14(2), 76–83 2020.

Molekul research summary: https://molekul.io/research/rumalon-gladiolus-2020. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards